✦ LIBER ✦

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial

✍ Scribed by Shi-Ming Tu; Randall E Millikan; Bayabel Mengistu; Ebrahim S Delpassand; Robert J Amato; Lance C Pagliaro; Danai Daliani; Christos N Papandreou; Terry L Smith; Jeri Kim; Donald A Podoloff; Christopher J Logothetis

Book ID: 117276437
Publisher: The Lancet
Year: 2001
Tongue: English
Weight: 464 KB
Volume: 357
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(00)03639-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined androgen deprivation therapy an

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

✍ Padraig Warde; Malcolm Mason; Keyue Ding; Peter Kirkbride; Michael Brundage; Ric 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 255 KB

Phase II trial of oral cyclophosphamide,

Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinoma

✍ Beth Hellerstedt; Kenneth J. Pienta; Bruce G. Redman; Peg Esper; Rodney Dunn; Ju 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract ## BACKGROUND The authors evaluated the combination of oral cyclophosphamide, oral prednisone, and diethylstilbestrol (DES) in patients with androgen‐independent prostate carcinoma (AIPC). ## METHODS Thirty‐seven patients with prostate carcinoma refractory to androgen ablation who ha

Re: Combined Androgen Deprivation Therap

Re: Combined Androgen Deprivation Therapy and Radiation Therapy for Locally Advanced Prostate Cancer: A Randomised, Phase 3 Trial

✍ Fred Saad 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Re: Combined Androgen Deprivation Therap

Re: Combined Androgen Deprivation Therapy and Radiation Therapy for Locally Advanced Prostate Cancer: A Randomised, Phase 3 Trial

✍ Walsh, Patrick C. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 98 KB

Phase II Trial of the Antiestrogen Torem

Phase II Trial of the Antiestrogen Toremifene for Androgen-Independent Prostate Cancer

✍ Matthew R. Smith; Philip W. Kantoff; William Oh; Grace Elson; Judith Manola; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Phase II trial of cyclophosphamide, vinc

Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma

✍ Danai D. Daliani; Vasily Assikis; Shi-Ming Tu; Christos N. Papandreou; Lance C. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## Abstract ## BACKGROUND In this Phase II study, the authors assessed the toxicity and anti‐tumor activity of a combination of oral cyclophosphamide, oral low‐dose dexamethasone, and intravenous vincristine (CVD) in patients with metastatic androgen‐independent prostate carcinoma (AI‐PCa). ## ME